95 results on '"Chittaganpitch M"'
Search Results
2. Human respiratory syncytial virus and influenza seasonality patterns-Early findings from the WHO global respiratory syncytial virus surveillance
- Author
-
Chadha, M, Hirve, S, Bancej, C, Barr, I, Baumeister, E, Caetano, B, Chittaganpitch, M, Darmaa, B, Ellis, J, Fasce, R, Kadjo, H, Jackson, S, Leung, V, Pisareva, M, Moyes, J, Naguib, A, Tivane, A, Zhang, W, Chadha, M, Hirve, S, Bancej, C, Barr, I, Baumeister, E, Caetano, B, Chittaganpitch, M, Darmaa, B, Ellis, J, Fasce, R, Kadjo, H, Jackson, S, Leung, V, Pisareva, M, Moyes, J, Naguib, A, Tivane, A, and Zhang, W
- Abstract
BACKGROUND: Human respiratory syncytial virus (RSV) causes illnesses among all age groups and presents a burden to healthcare services. To better understand the epidemiology and seasonality of RSV in different geographical areas, the World Health Organization (WHO) coordinated a pilot initiative to access the feasibility of establishing RSV surveillance using the existing Global Influenza Surveillance and Response System (GISRS) platform. OBJECTIVES: To describe and compare RSV and influenza seasonality in countries in the northern andsouthern temperate, and tropics during the period January 2017 to April 2019. METHODS: Fourteen countries in six WHO regions participating in the GISRS were invited for the pilot. Hospitalized patients presenting with severe acute respiratory illness (SARI), SARI without fever and outpatients presenting with acute respiratory illness (ARI) were enrolled from January 2017 to April 2019. The expected minimum sample size was 20 samples per week, year-round, per country. Real-time RT-PCR was used to detect RSV and influenza viruses. Results were uploaded to the WHO FluMart platform. RESULTS: Annual seasonality of RSV was observed in all countries, which overlapped to a large extent with the influenza activity. In countries, in temperate regions RSV peaked in the autumn/winter months. In Egypt, a subtropical country, RSV activity peaked in the cooler season. In the tropical regions, RSV peaked during the rainy seasons. CONCLUSION: Early findings from the WHO RSV surveillance pilot based on the GISRS suggest annual seasonal patterns for of RSV circulation that overlap with influenza. RSV surveillance needs to be continued for several more seasons to establish seasonality patterns to inform prevention and control strategies.
- Published
- 2020
3. Results from the WHO external quality assessment for the respiratory syncytial virus pilot, 2016-17
- Author
-
Jackson, S, Peret, TCT, Ziegler, TT, Thornburg, NJ, Besselaar, T, Broor, S, Barr, I, Baumeister, E, Chadha, M, Chittaganpitch, M, Darmaa, B, Ellis, J, Fasce, R, Herring, B, Herve, K, Hirve, S, Li, Y, Pisareva, M, Moen, A, Naguib, A, Palekar, R, Potdar, V, Siqueira, M, Treurnicht, F, Tivane, A, Venter, M, Wairagkar, N, Zambon, M, Zhang, W, Jackson, S, Peret, TCT, Ziegler, TT, Thornburg, NJ, Besselaar, T, Broor, S, Barr, I, Baumeister, E, Chadha, M, Chittaganpitch, M, Darmaa, B, Ellis, J, Fasce, R, Herring, B, Herve, K, Hirve, S, Li, Y, Pisareva, M, Moen, A, Naguib, A, Palekar, R, Potdar, V, Siqueira, M, Treurnicht, F, Tivane, A, Venter, M, Wairagkar, N, Zambon, M, and Zhang, W
- Abstract
BACKGROUND: External quality assessments (EQAs) for the molecular detection of respiratory syncytial virus (RSV) are necessary to ensure the provision of reliable and accurate results. One of the objectives of the pilot of the World Health Organization (WHO) Global RSV Surveillance, 2016-2017, was to evaluate and standardize RSV molecular tests used by participating countries. This paper describes the first WHO RSV EQA for the molecular detection of RSV. METHODS: The WHO implemented the pilot of Global RSV Surveillance based on the WHO Global Influenza Surveillance and Response System (GISRS) from 2016 to 2018 in 14 countries. To ensure standardization of tests, 13 participating laboratories were required to complete a 12 panel RSV EQA prepared and distributed by the Centers for Disease Control and Prevention (CDC), USA. The 14th laboratory joined the pilot late and participated in a separate EQA. Laboratories evaluated a RSV rRT-PCR assay developed by CDC and compared where applicable, other Laboratory Developed Tests (LDTs) or commercial assays already in use at their laboratories. RESULTS: Laboratories performed well using the CDC RSV rRT-PCR in comparison with LDTs and commercial assays. Using the CDC assay, 11 of 13 laboratories reported correct results. Two laboratories each reported one false-positive finding. Of the laboratories using LDTs or commercial assays, results as assessed by Ct values were 100% correct for 1/5 (20%). With corrective actions, all laboratories achieved satisfactory outputs. CONCLUSIONS: These findings indicate that reliable results can be expected from this pilot. Continued participation in EQAs for the molecular detection of RSV is recommended.
- Published
- 2020
4. Global Role and Burden of Influenza in Pediatric Respiratory Hospitalizations, 1982-2012: A Systematic Analysis
- Author
-
Lafond, K.E., Nair, H., Rasooly, M.H., Valente, F., Booy, R., Rahman, M., Kitsutani, P., Yu, H., Guzman, G., Coulibaly, D., Armero, J., Jima, D., Howie, S.R., Ampofo, W., Mena, R., Chadha, M., Sampurno, O.D., Emukule, G.O., Nurmatov, Z., Corwin, A., Heraud, J.M., Noyola, D.E., Cojocaru, R., Nymadawa, P., Barakat, A., Adedeji, A., Horoch, M. von, Olveda, R., Nyatanyi, T., Venter, M., Mmbaga, V., Chittaganpitch, M., Nguyen, T.H., Theo, A., Whaley, M., Azziz-Baumgartner, E., Bresee, J., Campbell, H., Widdowson, M.A., Lafond, K.E., Nair, H., Rasooly, M.H., Valente, F., Booy, R., Rahman, M., Kitsutani, P., Yu, H., Guzman, G., Coulibaly, D., Armero, J., Jima, D., Howie, S.R., Ampofo, W., Mena, R., Chadha, M., Sampurno, O.D., Emukule, G.O., Nurmatov, Z., Corwin, A., Heraud, J.M., Noyola, D.E., Cojocaru, R., Nymadawa, P., Barakat, A., Adedeji, A., Horoch, M. von, Olveda, R., Nyatanyi, T., Venter, M., Mmbaga, V., Chittaganpitch, M., Nguyen, T.H., Theo, A., Whaley, M., Azziz-Baumgartner, E., Bresee, J., Campbell, H., and Widdowson, M.A.
- Abstract
Contains fulltext : 165650.PDF (publisher's version ) (Open Access), BACKGROUND: The global burden of pediatric severe respiratory illness is substantial, and influenza viruses contribute to this burden. Systematic surveillance and testing for influenza among hospitalized children has expanded globally over the past decade. However, only a fraction of the data has been used to estimate influenza burden. In this analysis, we use surveillance data to provide an estimate of influenza-associated hospitalizations among children worldwide. METHODS AND FINDINGS: We aggregated data from a systematic review (n = 108) and surveillance platforms (n = 37) to calculate a pooled estimate of the proportion of samples collected from children hospitalized with respiratory illnesses and positive for influenza by age group (<6 mo, <1 y, <2 y, <5 y, 5-17 y, and <18 y). We applied this proportion to global estimates of acute lower respiratory infection hospitalizations among children aged <1 y and <5 y, to obtain the number and per capita rate of influenza-associated hospitalizations by geographic region and socio-economic status. Influenza was associated with 10% (95% CI 8%-11%) of respiratory hospitalizations in children <18 y worldwide, ranging from 5% (95% CI 3%-7%) among children <6 mo to 16% (95% CI 14%-20%) among children 5-17 y. On average, we estimated that influenza results in approximately 374,000 (95% CI 264,000 to 539,000) hospitalizations in children <1 y-of which 228,000 (95% CI 150,000 to 344,000) occur in children <6 mo-and 870,000 (95% CI 610,000 to 1,237,000) hospitalizations in children <5 y annually. Influenza-associated hospitalization rates were more than three times higher in developing countries than in industrialized countries (150/100,000 children/year versus 48/100,000). However, differences in hospitalization practices between settings are an important limitation in interpreting these findings. CONCLUSIONS: Influenza is an important contributor to respiratory hospitalizations among young children worldwide. Increasing influen
- Published
- 2016
5. Effectiveness of Non-pharmaceutical Interventions in Controlling an Influenza A Outbreak in a School, Thailand, November 2007
- Author
-
Sonthichai C, Iamsirithaworn S, Cummings D, Shokekird P, Niramitsantipong A, Khumket S, Chittaganpitch M, and Justin Lessler
- Subjects
education ,Article - Abstract
Non-pharmaceutical interventions are often recommended as a component of integrated control measures for pandemic influenza, but the effectiveness needs to be evaluated. An outbreak of influenza A (H1N1) in northern Thailand in November 2007 offered opportunity to evaluate these interventions. An investigation was conducted to describe the outbreak, evaluate effectiveness of non-pharmaceutical interventions and assess surge capacity of health agencies. A descriptive study was conducted by interviewing students and personnel in a school. We characterized transmission of the virus in this outbreak and explored effects of control measures. We identified that 44% of the students and teachers developed influenza during the 19-day outbreak. Non-pharmaceutical interventions including school closure, setting up a field hospital and community health education were implemented. These measures possibly limited the outbreak spreading to other schools nearby. Surveillance and preparedness plans could be strengthened to respond to pandemic and inter-pandemic influenza by using non-pharmaceutical interventions.
- Published
- 2013
6. Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa.
- Author
-
Smith D., Buchy P., Kei I.P., Kok T., Lin C., McPhie K., Mohd A., Olveda R., Panayotou T., Rawlinson W., Scott L., D'Souza H., Barr I.G., Kelso A., Shaw R., Komadina N., Hurt A.C., Ernest J., Deng Y.-M., Iannello P., Besselaar T.G., Birch C., Chittaganpitch M., Chiu S.-C., Dwyer D., Guigon A., Harrower B., Smith D., Buchy P., Kei I.P., Kok T., Lin C., McPhie K., Mohd A., Olveda R., Panayotou T., Rawlinson W., Scott L., D'Souza H., Barr I.G., Kelso A., Shaw R., Komadina N., Hurt A.C., Ernest J., Deng Y.-M., Iannello P., Besselaar T.G., Birch C., Chittaganpitch M., Chiu S.-C., Dwyer D., Guigon A., and Harrower B.
- Abstract
The neuraminidase inhibitors (NAIs) are an effective class of antiviral drugs for the treatment of influenza A and B infections. Until recently, only a low prevalence of NAI resistance (<1%) had been detected in circulating viruses. However, surveillance in Europe in late 2007 revealed significant numbers of A(H1N1) influenza strains with a H274Y neuraminidase mutation that were highly resistant to the NAI oseltamivir. We examined 264 A(H1N1) viruses collected in 2008 from South Africa, Oceania and SE Asia for their susceptibility to NAIs oseltamivir, zanamivir and peramivir in a fluorescence-based neuraminidase inhibition assay. Viruses with reduced oseltamivir susceptibility were further analysed by pyrosequencing assay. The frequency of the oseltamivir-resistant H274Y mutant increased significantly after May 2008, resulting in an overall proportion of 64% (168/264) resistance among A(H1N1) strains, although this subtype represented only 11.6% of all isolates received during 2008. H274Y mutant viruses demonstrated on average a 1466-fold reduction in oseltamivir susceptibility and 527-fold reduction in peramivir sensitivity compared to wild-type A(H1N1) viruses. The mutation had no impact on zanamivir susceptibility. Ongoing surveillance is essential to monitor how these strains may spread or persist in the future and to evaluate the effectiveness of treatments against them. © 2009 Elsevier B.V. All rights reserved.
- Published
- 2012
7. Hospitalizations for Acute Lower Respiratory Tract Infection Due to Respiratory Syncytial Virus in Thailand, 2008-2011
- Author
-
Naorat, S., primary, Chittaganpitch, M., additional, Thamthitiwat, S., additional, Henchaichon, S., additional, Sawatwong, P., additional, Srisaengchai, P., additional, Lu, Y., additional, Chuananon, S., additional, Amornintapichet, T., additional, Chantra, S., additional, Erdman, D. D., additional, Maloney, S. A., additional, Akarasewi, P., additional, and Baggett, H. C., additional
- Published
- 2013
- Full Text
- View/download PDF
8. Respiratory Syncytial Virus Circulation in Seven Countries With Global Disease Detection Regional Centers
- Author
-
Haynes, A. K., primary, Manangan, A. P., additional, Iwane, M. K., additional, Sturm-Ramirez, K., additional, Homaira, N., additional, Brooks, W. A., additional, Luby, S., additional, Rahman, M., additional, Klena, J. D., additional, Zhang, Y., additional, Yu, H., additional, Zhan, F., additional, Dueger, E., additional, Mansour, A. M., additional, Azazzy, N., additional, McCracken, J. P., additional, Bryan, J. P., additional, Lopez, M. R., additional, Burton, D. C., additional, Bigogo, G., additional, Breiman, R. F., additional, Feikin, D. R., additional, Njenga, K., additional, Montgomery, J., additional, Cohen, A. L., additional, Moyes, J., additional, Pretorius, M., additional, Cohen, C., additional, Venter, M., additional, Chittaganpitch, M., additional, Thamthitiwat, S., additional, Sawatwong, P., additional, Baggett, H. C., additional, Luber, G., additional, and Gerber, S. I., additional
- Published
- 2013
- Full Text
- View/download PDF
9. High Prevalence of Cryptococcal Infection Among HIV-Infected Patients Hospitalized With Pneumonia in Thailand
- Author
-
Harris, J. R., primary, Lindsley, M. D., additional, Henchaichon, S., additional, Poonwan, N., additional, Naorat, S., additional, Prapasiri, P., additional, Chantra, S., additional, Ruamcharoen, F., additional, Chang, L. S., additional, Chittaganpitch, M., additional, Mehta, N., additional, Peruski, L., additional, Maloney, S. A., additional, Park, B. J., additional, and Baggett, H. C., additional
- Published
- 2011
- Full Text
- View/download PDF
10. Serology as an Adjunct to Polymerase Chain Reaction Assays for Surveillance of Acute Respiratory Virus Infections
- Author
-
Sawatwong, P., primary, Chittaganpitch, M., additional, Hall, H., additional, Peruski, L. F., additional, Xu, X., additional, Baggett, H. C., additional, Fry, A. M., additional, Erdman, D. D., additional, and Olsen, S. J., additional
- Published
- 2011
- Full Text
- View/download PDF
11. Evidence for Subclinical Avian Influenza Virus Infections Among Rural Thai Villagers
- Author
-
Khuntirat, B. P., primary, Yoon, I.-K., additional, Blair, P. J., additional, Krueger, W. S., additional, Chittaganpitch, M., additional, Putnam, S. D., additional, Supawat, K., additional, Gibbons, R. V., additional, Pattamadilok, S., additional, Sawanpanyalert, P., additional, Heil, G. L., additional, Friary, J. A., additional, Capuano, A. W., additional, and Gray, G. C., additional
- Published
- 2011
- Full Text
- View/download PDF
12. A preliminary analysis of the epidemiology of influenza A(H1N1)v virus infection in Thailand from early outbreak data, June-July 2009
- Author
-
de Silva, U C, primary, Warachit, J, additional, Waicharoen, S, additional, and Chittaganpitch, M, additional
- Published
- 2009
- Full Text
- View/download PDF
13. Seroprevalence of Anti-H5 Antibody among Thai Health Care Workers after Exposure to Avian Influenza (H5N1) in a Tertiary Care Center
- Author
-
Apisarnthanarak, A., primary, Erb, S., additional, Stephenson, I., additional, Katz, J. M., additional, Chittaganpitch, M., additional, Sangkitporn, S., additional, Kitphati, R., additional, Thawatsupha, P., additional, Waicharoen, S., additional, Pinitchai, U., additional, Apisarnthanarak, P., additional, Fraser, V. J., additional, and Mundy, L. M., additional
- Published
- 2005
- Full Text
- View/download PDF
14. Human coronavirus infections in rural Thailand: a comprehensive study using real-time reverse-transcription polymerase chain reaction assays.
- Author
-
Dare RK, Fry AM, Chittaganpitch M, Sawanpanyalert P, Olsen SJ, Erdman DD, Dare, Ryan K, Fry, Alicia M, Chittaganpitch, Malinee, Sawanpanyalert, Pathom, Olsen, Sonja J, and Erdman, Dean D
- Abstract
Background: We sought to determine whether infections with human coronaviruses (HCoVs) 229E, OC43, HKU1, and NL63 are associated with pneumonia and to define the epidemiology of HCoV infection in rural Thailand.Methods: We developed a real-time reverse-transcription polymerase chain reaction (RT-PCR) assay panel for the recognized HCoV types and compared HCoV infections in patients hospitalized with pneumonia, outpatients with influenza-like illness, and asymptomatic control patients between September 2003 and August 2005.Results: During study year 1, 43 (5.9%) of 734 patients with pneumonia had HCoV infections; 72.1% of the infections were with OC43. During study year 2, when control patients were available, 21 (1.8%) of 1156 patients with pneumonia, 12 (2.3%) of 513 outpatients, and 6 (2.1%) of 281 control patients had HCoV infections. Compared with infection in control patients, infection with any HCoV type or with all types combined was not associated with pneumonia (adjusted odds ratio for all HCoV types, 0.67 [95% confidence interval, 0.26-1.75]; P=.40). HCoV infections were detected throughout both study years; 93.6% of OC43 infections in the first year occurred from January through March.Conclusions: HCoV infections were infrequently detected in rural Thailand by use of sensitive real-time RT-PCR assays. We found no association between HCoV infection and illness. However, we noted year-to-year variation in the prevalence of HCoV strains, which likely influenced our results. [ABSTRACT FROM AUTHOR]- Published
- 2007
- Full Text
- View/download PDF
15. Atypical avian influenza (H5N1)
- Author
-
Apisarnthanarak, A., Kitphati, R., Thongphubeth, K., Patoomanunt, P., Anthanont, P., Auwanit, W., Thawatsupha, P., Chittaganpitch, M., Saeng-Aroon, S., Waicharoen, S., Apisarnthanarak, P., Storch, G. A., Mundy, L. M., and Victoria Fraser
- Subjects
Adult ,animal structures ,Gastrointestinal Diseases ,Health Personnel ,lcsh:Medicine ,Avian influenza ,lcsh:Infectious and parasitic diseases ,Fatal Outcome ,unusual presentation ,Influenza, Human ,Animals ,Humans ,lcsh:RC109-216 ,Poultry Diseases ,Influenza A Virus, H5N1 Subtype ,healthcare workers ,lcsh:R ,Dispatch ,virus diseases ,H5N1 ,Thailand ,Influenza A virus ,Influenza in Birds ,Female ,influenza ,Chickens - Abstract
We report the first case of avian influenza in a patient with fever and diarrhea but no respiratory symptoms. Avian influenza should be included in the differential diagnosis for patients with predominantly gastrointestinal symptoms, particularly if they have a history of exposure to poultry.
16. Characterization of H5N1 influenza viruses isolated from humans in vitro
- Author
-
Kameoka Masanori, Bai Gui-Rong, Kanai Yuta, Waicharoen Sunthareeya, Chittaganpitch Malinee, Li Yong-Gang, Takeda Naokazu, Ikuta Kazuyoshi, and Sawanpanyalert Pathom
- Subjects
Infectious and parasitic diseases ,RC109-216 - Abstract
Abstract Since December 1997, highly pathogenic avian influenza A H5N1viruses have swept through poultry populations across Asian countries and been transmitted into African and European countries. We characterized 6 avian influenza H5N1 viruses isolated from humans in 2004 in Thailand. A highly pathogenic (HP) KAN353 strain showed faster replication and higher virulence in embryonated eggs compared to other strains, especially compared to the low pathogenic (LP) SP83 strain. HP KAN353 also showed strong cytopathogenicity compared to SP83 in Madin-Darby canine kidney cells. Interestingly, LP SP83 induced smaller plaques compared to other strains, especially HP KAN353. PB2 amino acid 627E may contribute to low virulence, whereas either PB2 amino acid 627 K or the combination of 627E/701N seems to be associated with high virulence. The in vitro assays used in this study may provide the basis for assessing the pathogenesis of influenza H5N1 viruses in vivo.
- Published
- 2010
- Full Text
- View/download PDF
17. Probable person-to-person transmission of avian influenza A (H5N1).
- Author
-
Ungchusak K, Auewarakul P, Dowell SF, Kitphati R, Auwanit W, Puthavathana P, Uiprasertkul M, Boonnak K, Pittayawonganon C, Cox NJ, Zaki SR, Thawatsupha P, Chittaganpitch M, Khontong R, Simmerman JM, Chunsutthiwat S, Ungchusak, Kumnuan, Auewarakul, Prasert, Dowell, Scott F, and Kitphati, Rungrueng
- Abstract
Background: During 2004, a highly pathogenic avian influenza A (H5N1) virus caused poultry disease in eight Asian countries and infected at least 44 persons, killing 32; most of these persons had had close contact with poultry. No evidence of efficient person-to-person transmission has yet been reported. We investigated possible person-to-person transmission in a family cluster of the disease in Thailand.Methods: For each of the three involved patients, we reviewed the circumstances and timing of exposures to poultry and to other ill persons. Field teams isolated and treated the surviving patient, instituted active surveillance for disease and prophylaxis among exposed contacts, and culled the remaining poultry surrounding the affected village. Specimens from family members were tested by viral culture, microneutralization serologic analysis, immunohistochemical assay, reverse-transcriptase-polymerase-chain-reaction (RT-PCR) analysis, and genetic sequencing.Results: The index patient became ill three to four days after her last exposure to dying household chickens. Her mother came from a distant city to care for her in the hospital, had no recognized exposure to poultry, and died from pneumonia after providing 16 to 18 hours of unprotected nursing care. The aunt also provided unprotected nursing care; she had fever five days after the mother first had fever, followed by pneumonia seven days later. Autopsy tissue from the mother and nasopharyngeal and throat swabs from the aunt were positive for influenza A (H5N1) by RT-PCR. No additional chains of transmission were identified, and sequencing of the viral genes identified no change in the receptor-binding site of hemagglutinin or other key features of the virus. The sequences of all eight viral gene segments clustered closely with other H5N1 sequences from recent avian isolates in Thailand.Conclusions: Disease in the mother and aunt probably resulted from person-to-person transmission of this lethal avian influenzavirus during unprotected exposure to the critically ill index patient. [ABSTRACT FROM AUTHOR]- Published
- 2005
18. First Round of External Quality Assessment Scheme for SARS-CoV-2 Laboratories During the COVID-19 Pandemic in Thailand.
- Author
-
Saeng-Aroon S, Changsom D, Boonmuang R, Waicharoen S, Buayai K, Okada P, Uppapong B, Chittaganpitch M, Soisangwan P, Praphasiri P, and Skaggs BA
- Subjects
- Humans, SARS-CoV-2 genetics, Laboratories, Pandemics prevention & control, Thailand epidemiology, RNA, Viral genetics, COVID-19
- Abstract
The emergence of SARS-CoV-2 necessitated the rapid deployment of tests to diagnose COVID-19. To monitor the accuracy of testing across the COVID-19 laboratory network in Thailand, the Department of Medical Sciences under the Ministry of Public Health launched a national external quality assessment (EQA) scheme using samples containing inactivated SARS-CoV-2 culture supernatant from a predominant strain in the early phase of the Thailand outbreak. All 197 laboratories in the network participated; 93% (n=183) of which reported correct results for all 6 EQA samples. Ten laboratories reported false-negative results, mostly for samples with low viral concentrations, and 5 laboratories reported false-positive results (1 laboratory reported false positives and false negatives). An intralaboratory investigation of 14 laboratories reporting incorrect results revealed 2 main causes of error: (1) RNA contamination of the rRT-PCR reaction and (2) poor-quality RNA extraction. Specific reagent combinations were significantly associated with false-negative reports. Thailand's approach to national EQA for SARS-CoV-2 can serve as a roadmap for other countries interested in implementing a national EQA program to ensure laboratories provide accurate testing results, which is crucial in diagnosis, prevention, and control strategies. A national EQA program can be less costly and thus more sustainable than commercial EQA programs. National EQA is recommended to detect and correct testing errors and provide postmarket surveillance for diagnostic test performance.
- Published
- 2023
- Full Text
- View/download PDF
19. Functioning of the International Health Regulations during the COVID-19 pandemic.
- Author
-
Aavitsland P, Aguilera X, Al-Abri SS, Amani V, Aramburu CC, Attia TA, Blumberg LH, Chittaganpitch M, Le Duc JW, Li D, Mokhtariazad T, Moussif M, Ojo OE, Okwo-Bele JM, Saito T, Sall AA, Salter MWAP, Sohn M, and Wieler LH
- Subjects
- COVID-19 epidemiology, Global Health statistics & numerical data, Humans, International Health Regulations statistics & numerical data, International Health Regulations trends, World Health Organization, COVID-19 prevention & control, Global Health trends, International Health Regulations organization & administration, Pandemics prevention & control
- Published
- 2021
- Full Text
- View/download PDF
20. Etiology and Clinical Characteristics of Severe Pneumonia Among Young Children in Thailand: Pneumonia Etiology Research for Child Health (PERCH) Case-Control Study Findings, 2012-2013.
- Author
-
Bunthi C, Rhodes J, Thamthitiwat S, Higdon MM, Chuananon S, Amorninthapichet T, Paveenkittiporn W, Chittaganpitch M, Sawatwong P, Hammitt LL, Feikin DR, Murdoch DR, Deloria-Knoll M, O'Brien KL, Prosperi C, Maloney SA, Baggett HC, and Akarasewi P
- Subjects
- AIDS-Related Opportunistic Infections diagnosis, AIDS-Related Opportunistic Infections epidemiology, AIDS-Related Opportunistic Infections etiology, AIDS-Related Opportunistic Infections prevention & control, Bayes Theorem, Case-Control Studies, Child Health, Child, Preschool, Developing Countries, Female, Hospitalization, Humans, Infant, Logistic Models, Male, Odds Ratio, Patient Acuity, Pneumonia epidemiology, Pneumonia prevention & control, Risk Factors, Thailand epidemiology, Pneumonia diagnosis, Pneumonia etiology
- Abstract
Background: Pneumonia remains the leading cause of death among children <5 years of age beyond the neonatal period in Thailand. Using data from the Pneumonia Etiology Research for Child Health (PERCH) Study, we provide a detailed description of pneumonia cases and etiology in Thailand to inform local treatment and prevention strategies in this age group., Methods: PERCH, a multi-country case-control study, evaluated the etiology of hospitalized cases of severe and very severe pneumonia among children 1-59 months of age. The Thailand site enrolled children for 24 consecutive months during January 2012-February 2014 with staggered start dates in 2 provinces. Cases were children hospitalized with pre-2013 WHO-defined severe or very severe pneumonia. Community controls were randomly selected from health services registries in each province. Analyses were restricted to HIV-negative cases and controls. We calculated adjusted odds ratios (ORs) and 95% CIs comparing organism prevalence detected by nasopharyngeal/oropharyngeal (NP/OP) polymerase chain reaction between cases and controls. The PERCH Integrated Analysis (PIA) used Bayesian latent variable analysis to estimate pathogen-specific etiologic fractions and 95% credible intervals., Results: Over 96% of both cases (n = 223) and controls (n = 659) had at least 1 organism detected; multiple organisms were detected in 86% of cases and 88% of controls. Among 98 chest Radiograph positive (CXR+) cases, respiratory syncytial virus (RSV) had the highest NP/OP prevalence (22.9%) and the strongest association with case status (OR 20.5; 95% CI: 10.2, 41.3) and accounted for 34.6% of the total etiologic fraction. Tuberculosis (TB) accounted for 10% (95% CrI: 1.6-26%) of the etiologic fraction among CXR+ cases., Discussion: More than one-third of hospitalized cases of severe and very severe CXR+ pneumonia among children 1-59 months of age in Thailand were attributable to RSV. TB accounted for 10% of cases, supporting evaluation for TB among children hospitalized with pneumonia in high-burden settings. Similarities in pneumonia etiology in Thailand and other PERCH sites suggest that global control strategies based on PERCH study findings are relevant to Thailand and similar settings., (Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc.)
- Published
- 2021
- Full Text
- View/download PDF
21. Knowledge, attitude/perception, and practice related to seasonal influenza vaccination among caregivers of young Thai children: A cross-sectional study.
- Author
-
Thanee C, Kittikraisak W, Sinthuwattanawibool C, Roekworachai K, Klinklom A, Kornsitthikul K, Jirasakpisarn S, Srirompotong U, Chittaganpitch M, Dawood FS, Suntarattiwong P, Mott JA, and Chotpitayasunondh T
- Subjects
- Adult, Child, Preschool, Female, Humans, Infant, Male, Thailand, Health Knowledge, Attitudes, Practice, Influenza Vaccines, Influenza, Human prevention & control, Parents, Perception, Surveys and Questionnaires, Vaccination
- Abstract
Background: Seasonal influenza vaccination uptake among young children in Thailand is low despite national recommendation for vaccination. We implemented a knowledge, attitude/perception, and practice survey to understand determinants of influenza vaccination in children aged six months to two years., Methods: Using a cross-sectional design, we interviewed caregivers of 700 children in seven hospitals using a structured questionnaire to collect information on caregivers' and children's demographic characteristics, and caregivers' knowledge of influenza illness and national vaccine recommendation, attitude/perception toward influenza vaccine, and information sources. We verified children's influenza vaccination status against medical records (vaccinated vs. unvaccinated). Logistic regression was used to examine factors independently associated with children receiving influenza vaccination in the 2018 season using the dataset restricted to only children's parents. Variables associated with vaccination at p-value ≤0.20 were included in subsequent multivariable logistic models. Significant independent determinants of children's influenza vaccination and collinearity of covariates were assessed. The final model was constructed using a stepwise backward elimination approach with variables significant at p-value <0.05 retained in the model., Results: During August 2018-February 2019, 700 children's caregivers completed the questionnaire; 61 (9%) were caregivers of vaccinated children. Caregivers of the vaccinated children were statistically more likely to have higher education (61% vs. 38%; p-value<0.01) and to know of influenza illness (93% vs. 76%; p-value = 0.03) than those of the unvaccinated group. Factors associated with children receiving influenza vaccination were identifying healthcare providers as a primary source of information about influenza illness for parents (adjusted odds ratio [aOR], 2.8; 95% confidence interval [CI], 1.3-6.0), parents' strongly agreeing with the national recommendation for influenza vaccination in young children (aOR, 2.9; 95% CI, 1.5-5.9), using health insurance provided by the government or parent's employer for children's doctor visits (aOR, 2.6; 95% CI, 1.1-6.6), and the children's history of receiving influenza vaccination in the 2017 season or earlier (aOR, 3.2; 95% CI, 1.4-7.8)., Conclusion: The majority of caregivers of children in this study had knowledge of influenza illness and influenza vaccine. Caregivers reported various sources of information regarding influenza illness and the vaccine, but healthcare providers remained the most trusted source. Children's history of influenza vaccination in prior season(s) was the strongest determinant of children being vaccinated for influenza in the current season., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2021
- Full Text
- View/download PDF
22. Antibody responses induced by trivalent inactivated influenza vaccine among pregnant and non-pregnant women in Thailand: A matched cohort study.
- Author
-
Nakphook S, Patumanond J, Shrestha M, Prasert K, Chittaganpitch M, Mott JA, and Praphasiri P
- Subjects
- Adult, Antibodies, Viral blood, Cohort Studies, Female, Humans, Influenza, Human epidemiology, Influenza, Human prevention & control, Influenza, Human virology, Pregnancy, Pregnant Women, Prospective Studies, Thailand epidemiology, Vaccination, Antibodies, Viral immunology, Antibody Formation immunology, Influenza A virus immunology, Influenza Vaccines administration & dosage, Influenza, Human immunology, Vaccines, Inactivated administration & dosage
- Abstract
Background: We compared influenza antibody titers among vaccinated and unvaccinated pregnant and non-pregnant women., Methods: During 1st June- 30th September 2018, four groups of cohort participants-vaccinated pregnant, unvaccinated pregnant, vaccinated non-pregnant, and unvaccinated non-pregnant women were selected by matching age, gestational age, and the week of vaccination. Serum antibody titers against each strain of 2018 Southern Hemisphere inactivated trivalent influenza vaccine (IIV3) were assessed by hemagglutination inhibition (HI) assay on Day 0 (pre-vaccination) and Day 28 (one month post-vaccination) serum samples. Geometric mean titer (GMT), GMT ratio (GMR), seroconversion (defined as ≥4 fold increase in HI titer), and seroprotection (i.e. HI titer ≥1:40) were compared across the study groups using multilevel regression analyses, controlling for previous year vaccination from medical records and baseline antibody levels., Results: A total of 132 participants were enrolled in the study (33 in each of the four study groups). The baseline GMTs for influenza A(H1N1), A(H3N2), and B vaccine strains were not significantly different among all four groups (all p-values >0.05). After one month, both vaccinated groups had significantly higher GMT, GMR, seroconversion, and seroprotection than their unvaccinated controls (all p-values <0.05). The seroconversion rate was over 60% for any strain among the vaccinated groups, with the highest (88.8%) observed against A(H1N1) in the vaccinated pregnant group. Similarly, at least 75% of the vaccinated participants developed seroprotective antibody levels against all three strains; the highest seroprotection was found against A(H3N2) at 92.6% among vaccinated non-pregnant participants. Antibody responses (post-vaccination GMT, GMR, seroconversion, and seroprotection) were not significantly different between pregnant and non-pregnant women for all three strains of IIV3 (all p>0.05)., Conclusions: The 2018 seasonal IIV3 was immunogenic against all three vaccine strains and pregnancy did not seem to alter the immune response to IIV3. These findings support the current influenza vaccination recommendations for pregnant women., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2021
- Full Text
- View/download PDF
23. Global burden of influenza-associated lower respiratory tract infections and hospitalizations among adults: A systematic review and meta-analysis.
- Author
-
Lafond KE, Porter RM, Whaley MJ, Suizan Z, Ran Z, Aleem MA, Thapa B, Sar B, Proschle VS, Peng Z, Feng L, Coulibaly D, Nkwembe E, Olmedo A, Ampofo W, Saha S, Chadha M, Mangiri A, Setiawaty V, Ali SS, Chaves SS, Otorbaeva D, Keosavanh O, Saleh M, Ho A, Alexander B, Oumzil H, Baral KP, Huang QS, Adebayo AA, Al-Abaidani I, von Horoch M, Cohen C, Tempia S, Mmbaga V, Chittaganpitch M, Casal M, Dang DA, Couto P, Nair H, Bresee JS, Olsen SJ, Azziz-Baumgartner E, Nuorti JP, and Widdowson MA
- Subjects
- Adult, Aged, Aged, 80 and over, Female, Humans, Influenza, Human economics, Male, Middle Aged, Respiratory Tract Infections economics, Young Adult, Cost of Illness, Hospitalization statistics & numerical data, Influenza, Human virology, Orthomyxoviridae physiology, Respiratory Tract Infections virology
- Abstract
Background: Influenza illness burden is substantial, particularly among young children, older adults, and those with underlying conditions. Initiatives are underway to develop better global estimates for influenza-associated hospitalizations and deaths. Knowledge gaps remain regarding the role of influenza viruses in severe respiratory disease and hospitalizations among adults, particularly in lower-income settings., Methods and Findings: We aggregated published data from a systematic review and unpublished data from surveillance platforms to generate global meta-analytic estimates for the proportion of acute respiratory hospitalizations associated with influenza viruses among adults. We searched 9 online databases (Medline, Embase, CINAHL, Cochrane Library, Scopus, Global Health, LILACS, WHOLIS, and CNKI; 1 January 1996-31 December 2016) to identify observational studies of influenza-associated hospitalizations in adults, and assessed eligible papers for bias using a simplified Newcastle-Ottawa scale for observational data. We applied meta-analytic proportions to global estimates of lower respiratory infections (LRIs) and hospitalizations from the Global Burden of Disease study in adults ≥20 years and by age groups (20-64 years and ≥65 years) to obtain the number of influenza-associated LRI episodes and hospitalizations for 2016. Data from 63 sources showed that influenza was associated with 14.1% (95% CI 12.1%-16.5%) of acute respiratory hospitalizations among all adults, with no significant differences by age group. The 63 data sources represent published observational studies (n = 28) and unpublished surveillance data (n = 35), from all World Health Organization regions (Africa, n = 8; Americas, n = 11; Eastern Mediterranean, n = 7; Europe, n = 8; Southeast Asia, n = 11; Western Pacific, n = 18). Data quality for published data sources was predominantly moderate or high (75%, n = 56/75). We estimate 32,126,000 (95% CI 20,484,000-46,129,000) influenza-associated LRI episodes and 5,678,000 (95% CI 3,205,000-9,432,000) LRI hospitalizations occur each year among adults. While adults <65 years contribute most influenza-associated LRI hospitalizations and episodes (3,464,000 [95% CI 1,885,000-5,978,000] LRI hospitalizations and 31,087,000 [95% CI 19,987,000-44,444,000] LRI episodes), hospitalization rates were highest in those ≥65 years (437/100,000 person-years [95% CI 265-612/100,000 person-years]). For this analysis, published articles were limited in their inclusion of stratified testing data by year and age group. Lack of information regarding influenza vaccination of the study population was also a limitation across both types of data sources., Conclusions: In this meta-analysis, we estimated that influenza viruses are associated with over 5 million hospitalizations worldwide per year. Inclusion of both published and unpublished findings allowed for increased power to generate stratified estimates, and improved representation from lower-income countries. Together, the available data demonstrate the importance of influenza viruses as a cause of severe disease and hospitalizations in younger and older adults worldwide., Competing Interests: I have read the journal’s policy and the authors of this manuscript have the following competing interests: H.N.: Grants from the Foundation for Influenza Epidemiology, grants from Innovative Medicines Initiative, grants from the WHO, personal fees from Bill and Melinda Gates Foundation, grants and personal fees from Sanofi, grants from National Institute of Health Research, personal fees from Janssen and personal fees from AbbVie, outside the submitted work. The remaining authors have declared that no competing interests exist.
- Published
- 2021
- Full Text
- View/download PDF
24. Global burden of acute lower respiratory infection associated with human metapneumovirus in children under 5 years in 2018: a systematic review and modelling study.
- Author
-
Wang X, Li Y, Deloria-Knoll M, Madhi SA, Cohen C, Ali A, Basnet S, Bassat Q, Brooks WA, Chittaganpitch M, Echavarria M, Fasce RA, Goswami D, Hirve S, Homaira N, Howie SRC, Kotloff KL, Khuri-Bulos N, Krishnan A, Lucero MG, Lupisan S, Mira-Iglesias A, Moore DP, Moraleda C, Nunes M, Oshitani H, Owor BE, Polack FP, O'Brien KL, Rasmussen ZA, Rath BA, Salimi V, Scott JAG, Simões EAF, Strand TA, Thea DM, Treurnicht FK, Vaccari LC, Yoshida LM, Zar HJ, Campbell H, and Nair H
- Subjects
- Acute Disease, Child, Preschool, Female, Humans, Infant, Infant, Newborn, Linear Models, Male, Metapneumovirus, Cost of Illness, Global Health statistics & numerical data, Paramyxoviridae Infections epidemiology, Respiratory Tract Infections epidemiology
- Abstract
Background: Human metapneumovirus is a common virus associated with acute lower respiratory infections (ALRIs) in children. No global burden estimates are available for ALRIs associated with human metapneumovirus in children, and no licensed vaccines or drugs exist for human metapneumovirus infections. We aimed to estimate the age-stratified human metapneumovirus-associated ALRI global incidence, hospital admissions, and mortality burden in children younger than 5 years., Methods: We estimated the global burden of human metapneumovirus-associated ALRIs in children younger than 5 years from a systematic review of 119 studies published between Jan 1, 2001, and Dec 31, 2019, and a further 40 high quality unpublished studies. We assessed risk of bias using a modified Newcastle-Ottawa Scale. We estimated incidence, hospital admission rates, and in-hospital case-fatality ratios (hCFRs) of human metapneumovirus-associated ALRI using a generalised linear mixed model. We applied incidence and hospital admission rates of human metapneumovirus-associated ALRI to population estimates to yield the morbidity burden estimates by age bands and World Bank income levels. We also estimated human metapneumovirus-associated ALRI in-hospital deaths and overall human metapneumovirus-associated ALRI deaths (both in-hospital and non-hospital deaths). Additionally, we estimated human metapneumovirus-attributable ALRI cases, hospital admissions, and deaths by combining human metapneumovirus-associated burden estimates and attributable fractions of human metapneumovirus in laboratory-confirmed human metapneumovirus cases and deaths., Findings: In 2018, among children younger than 5 years globally, there were an estimated 14·2 million human metapneumovirus-associated ALRI cases (uncertainty range [UR] 10·2 million to 20·1 million), 643 000 human metapneumovirus-associated hospital admissions (UR 425 000 to 977 000), 7700 human metapneumovirus-associated in-hospital deaths (2600 to 48 800), and 16 100 overall (hospital and community) human metapneumovirus-associated ALRI deaths (5700 to 88 000). An estimated 11·1 million ALRI cases (UR 8·0 million to 15·7 million), 502 000 ALRI hospital admissions (UR 332 000 to 762 000), and 11 300 ALRI deaths (4000 to 61 600) could be causally attributed to human metapneumovirus in 2018. Around 58% of the hospital admissions were in infants under 12 months, and 64% of in-hospital deaths occurred in infants younger than 6 months, of which 79% occurred in low-income and lower-middle-income countries., Interpretation: Infants younger than 1 year have disproportionately high risks of severe human metapneumovirus infections across all World Bank income regions and all child mortality settings, similar to respiratory syncytial virus and influenza virus. Infants younger than 6 months in low-income and lower-middle-income countries are at greater risk of death from human metapneumovirus-associated ALRI than older children and those in upper-middle-income and high-income countries. Our mortality estimates demonstrate the importance of intervention strategies for infants across all settings, and warrant continued efforts to improve the outcome of human metapneumovirus-associated ALRI among young infants in low-income and lower-middle-income countries., Funding: Bill & Melinda Gates Foundation., (Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
25. Results from the WHO external quality assessment for the respiratory syncytial virus pilot, 2016-17.
- Author
-
Jackson S, Peret TCT, Ziegler TT, Thornburg NJ, Besselaar T, Broor S, Barr I, Baumeister E, Chadha M, Chittaganpitch M, Darmaa B, Ellis J, Fasce R, Herring B, Herve K, Hirve S, Li Y, Pisareva M, Moen A, Naguib A, Palekar R, Potdar V, Siqueira M, Treurnicht F, Tivane A, Venter M, Wairagkar N, Zambon M, and Zhang W
- Subjects
- Humans, Laboratories standards, Molecular Diagnostic Techniques standards, Pilot Projects, RNA, Viral genetics, Respiratory Syncytial Virus, Human genetics, World Health Organization, Quality Assurance, Health Care statistics & numerical data, Respiratory Syncytial Virus Infections diagnosis, Respiratory Syncytial Virus, Human isolation & purification
- Abstract
Background: External quality assessments (EQAs) for the molecular detection of respiratory syncytial virus (RSV) are necessary to ensure the provision of reliable and accurate results. One of the objectives of the pilot of the World Health Organization (WHO) Global RSV Surveillance, 2016-2017, was to evaluate and standardize RSV molecular tests used by participating countries. This paper describes the first WHO RSV EQA for the molecular detection of RSV., Methods: The WHO implemented the pilot of Global RSV Surveillance based on the WHO Global Influenza Surveillance and Response System (GISRS) from 2016 to 2018 in 14 countries. To ensure standardization of tests, 13 participating laboratories were required to complete a 12 panel RSV EQA prepared and distributed by the Centers for Disease Control and Prevention (CDC), USA. The 14th laboratory joined the pilot late and participated in a separate EQA. Laboratories evaluated a RSV rRT-PCR assay developed by CDC and compared where applicable, other Laboratory Developed Tests (LDTs) or commercial assays already in use at their laboratories., Results: Laboratories performed well using the CDC RSV rRT-PCR in comparison with LDTs and commercial assays. Using the CDC assay, 11 of 13 laboratories reported correct results. Two laboratories each reported one false-positive finding. Of the laboratories using LDTs or commercial assays, results as assessed by Ct values were 100% correct for 1/5 (20%). With corrective actions, all laboratories achieved satisfactory outputs., Conclusions: These findings indicate that reliable results can be expected from this pilot. Continued participation in EQAs for the molecular detection of RSV is recommended., (© 2020 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd.)
- Published
- 2020
- Full Text
- View/download PDF
26. Human respiratory syncytial virus and influenza seasonality patterns-Early findings from the WHO global respiratory syncytial virus surveillance.
- Author
-
Chadha M, Hirve S, Bancej C, Barr I, Baumeister E, Caetano B, Chittaganpitch M, Darmaa B, Ellis J, Fasce R, Kadjo H, Jackson S, Leung V, Pisareva M, Moyes J, Naguib A, Tivane A, and Zhang W
- Subjects
- Global Health, Humans, Influenza, Human diagnosis, Orthomyxoviridae genetics, Orthomyxoviridae isolation & purification, Pilot Projects, Respiratory Syncytial Virus Infections diagnosis, Respiratory Syncytial Virus, Human genetics, Respiratory Syncytial Virus, Human isolation & purification, Respiratory Tract Infections diagnosis, Respiratory Tract Infections epidemiology, Respiratory Tract Infections virology, Seasons, World Health Organization, Influenza, Human epidemiology, Respiratory Syncytial Virus Infections epidemiology, Sentinel Surveillance
- Abstract
Background: Human respiratory syncytial virus (RSV) causes illnesses among all age groups and presents a burden to healthcare services. To better understand the epidemiology and seasonality of RSV in different geographical areas, the World Health Organization (WHO) coordinated a pilot initiative to access the feasibility of establishing RSV surveillance using the existing Global Influenza Surveillance and Response System (GISRS) platform., Objectives: To describe and compare RSV and influenza seasonality in countries in the northern andsouthern temperate, and tropics during the period January 2017 to April 2019., Methods: Fourteen countries in six WHO regions participating in the GISRS were invited for the pilot. Hospitalized patients presenting with severe acute respiratory illness (SARI), SARI without fever and outpatients presenting with acute respiratory illness (ARI) were enrolled from January 2017 to April 2019. The expected minimum sample size was 20 samples per week, year-round, per country. Real-time RT-PCR was used to detect RSV and influenza viruses. Results were uploaded to the WHO FluMart platform., Results: Annual seasonality of RSV was observed in all countries, which overlapped to a large extent with the influenza activity. In countries, in temperate regions RSV peaked in the autumn/winter months. In Egypt, a subtropical country, RSV activity peaked in the cooler season. In the tropical regions, RSV peaked during the rainy seasons., Conclusion: Early findings from the WHO RSV surveillance pilot based on the GISRS suggest annual seasonal patterns for of RSV circulation that overlap with influenza. RSV surveillance needs to be continued for several more seasons to establish seasonality patterns to inform prevention and control strategies., (© 2020 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd.)
- Published
- 2020
- Full Text
- View/download PDF
27. The epidemiology and estimated etiology of pathogens detected from the upper respiratory tract of adults with severe acute respiratory infections in multiple countries, 2014-2015.
- Author
-
Milucky J, Pondo T, Gregory CJ, Iuliano D, Chaves SS, McCracken J, Mansour A, Zhang Y, Aleem MA, Wolff B, Whitaker B, Whistler T, Onyango C, Lopez MR, Liu N, Rahman MZ, Shang N, Winchell J, Chittaganpitch M, Fields B, Maldonado H, Xie Z, Lindstrom S, Sturm-Ramirez K, Montgomery J, Wu KH, and Van Beneden CA
- Subjects
- Adult, Aged, Asymptomatic Diseases epidemiology, Bacteria genetics, Bacteria isolation & purification, Bangladesh, Bayes Theorem, Female, Guatemala, Humans, Male, Middle Aged, Models, Theoretical, Molecular Epidemiology, Nasopharynx microbiology, Oropharynx microbiology, Polymerase Chain Reaction, Viruses genetics, Viruses isolation & purification, Young Adult, Bacteria classification, Respiratory Tract Infections epidemiology, Respiratory Tract Infections microbiology, Viruses classification
- Abstract
Introduction: Etiology studies of severe acute respiratory infections (SARI) in adults are limited. We studied potential etiologies of SARI among adults in six countries using multi-pathogen diagnostics., Methods: We enrolled both adults with SARI (acute respiratory illness onset with fever and cough requiring hospitalization) and asymptomatic adults (adults hospitalized with non-infectious illnesses, non-household members accompanying SARI patients, adults enrolled from outpatient departments, and community members) in each country. Demographics, clinical data, and nasopharyngeal and oropharyngeal specimens were collected from both SARI patients and asymptomatic adults. Specimens were tested for presence of 29 pathogens utilizing the Taqman® Array Card platform. We applied a non-parametric Bayesian regression extension of a partially latent class model approach to estimate proportions of SARI caused by specific pathogens., Results: We enrolled 2,388 SARI patients and 1,135 asymptomatic adults from October 2013 through October 2015. We detected ≥1 pathogen in 76% of SARI patients and 67% of asymptomatic adults. Haemophilus influenzae and Streptococcus pneumoniae were most commonly detected (≥23% of SARI patients and asymptomatic adults). Through modeling, etiology was attributed to a pathogen in most SARI patients (range among countries: 57.3-93.2%); pathogens commonly attributed to SARI etiology included influenza A (14.4-54.4%), influenza B (1.9-19.1%), rhino/enterovirus (1.8-42.6%), and RSV (3.6-14.6%)., Conclusions: Use of multi-pathogen diagnostics and modeling enabled attribution of etiology in most adult SARI patients, despite frequent detection of multiple pathogens in the upper respiratory tract. Seasonal flu vaccination and development of RSV vaccine would likely reduce the burden of SARI in these populations., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2020
- Full Text
- View/download PDF
28. Metformin-induced suppression of IFN-α via mTORC1 signalling following seasonal vaccination is associated with impaired antibody responses in type 2 diabetes.
- Author
-
Saenwongsa W, Nithichanon A, Chittaganpitch M, Buayai K, Kewcharoenwong C, Thumrongwilainet B, Butta P, Palaga T, Takahashi Y, Ato M, and Lertmemongkolchai G
- Subjects
- Aged, Antibodies, Viral immunology, Antibody Affinity immunology, Diabetes Mellitus, Type 2 drug therapy, Female, Glyburide pharmacology, Glyburide therapeutic use, Hemagglutination Inhibition Tests, Humans, Immunoglobulin G metabolism, Influenza A Virus, H1N1 Subtype drug effects, Influenza A Virus, H1N1 Subtype immunology, Influenza A Virus, H3N2 Subtype drug effects, Influenza A Virus, H3N2 Subtype immunology, Influenza B virus drug effects, Influenza B virus immunology, Influenza Vaccines immunology, Male, Metformin therapeutic use, Monocytes drug effects, Monocytes metabolism, Virion drug effects, Virion immunology, Antibody Formation drug effects, Diabetes Mellitus, Type 2 immunology, Interferon-alpha pharmacology, Mechanistic Target of Rapamycin Complex 1 metabolism, Metformin pharmacology, Seasons, Signal Transduction drug effects, Vaccination
- Abstract
Diabetes mellitus (DM) patients are at an increased risk of complications following influenza-virus infection, seasonal vaccination (SV) is recommended. However, SV with trivalent influenza vaccine (TIV) can induce antibody and type-I interferon (IFN) responses, and the effect of anti-DM treatment on these responses is incompletely understood. We evaluated the antibody response and IFN-α expression in individuals with and without type 2 DM (T2DM) following SV, and examined the effects on anti-DM treatment. TIV elicited sero-protection in all groups, but antibody persistency was <8 months, except for the antibody response to B-antigens in non-DM. T2DM impaired the IgG avidity index, and T2DM showed a significantly decreased response against H1N1 and H3N2, in addition to delaying and reducing haemagglutination-inhibition persistency against influenza B-antigens in DM groups treated with metformin (Met-DM) or glibenclamide (GB-DM). Following TIV, the Met-DM and GB-DM groups exhibited reduced IFN-α expression upon stimulation with whole- and split-virion influenza vaccines. Suppression of IFN-α expression in the Met-DM group was associated with a reduction in the mechanistic target of rapamycin complex-1 pathway and impaired IgG avidity index. Thus, single-dose TIV each year might not be suitable for T2DM. Our data could aid the development of an efficacious influenza vaccine for T2DM.
- Published
- 2020
- Full Text
- View/download PDF
29. Immune response to influenza vaccination in ESRD patients undergoing hemodialysis vs. hemodiafiltration.
- Author
-
Nongnuch A, Ngampongpan W, Srichatrapimuk S, Wongsa A, Thongpraphai S, Boonarkart C, Sanmeema N, Chittaganpitch M, Auewarakul P, Tassaneetrithep B, Davenport A, and Phuphuakrat A
- Subjects
- Adult, Aged, Azotemia immunology, Azotemia pathology, Cell Proliferation genetics, Female, Hemagglutination Inhibition Tests, Hemodiafiltration, Humans, Influenza Vaccines immunology, Influenza, Human immunology, Influenza, Human virology, Kidney Failure, Chronic immunology, Kidney Failure, Chronic virology, Lymphocytes immunology, Male, Middle Aged, Renal Dialysis, T-Lymphocytes immunology, Vaccination, Vaccines administration & dosage, Immunity, Innate, Influenza Vaccines administration & dosage, Influenza, Human prevention & control, Kidney Failure, Chronic prevention & control
- Abstract
Background: On-line hemodiafiltration (HDF) clears more azotemic toxins compared to high-flux hemodialysis (HD). The response to vaccination is impaired in dialysis patients. We wished to determine whether the immune responses to influenza vaccine in dialysis patients treated by HDF were stronger than those treated by HD., Materials and Methods: We conducted a prospective cohort study in chronic dialysis patients during the 2016 and 2017 influenza seasons. All participants received a single standard dose of trivalent influenza vaccine, and we studied the elicited humoral immune response by hemagglutination inhibition test, and cell-mediated immune response by enumeration of lymphocyte cellular markers and proliferation assays., Results: We immunized 60 end-stage renal disease (ESRD) patients: 42 (70%) treated with HD and 18 patients (30%) with HDF. The median (interquartile range) age was 65.0 (55.0-74.5) years. All patients developed seroprotection to at least one influenza vaccine strain at one month post-vaccination, and did not differ between groups. By logistic regression, age was the only factor independently associated with seroconversion to all vaccine strains (odds ratio 0.89, 95% confidence interval 0.80-0.98; p = 0.022). Seroprotection to all vaccine strains was sustained for longer in patients treated with HDF, and the results remained the same after age adjustment. For cellular immune response, patients who seroconverted to all vaccine strains had higher CD38+ T cell subpopulations pre-vaccination. Patients treated by HDF had higher lymphocyte proliferation to circulating influenza A strains., Conclusions: Seroconversion to all influenza vaccine strains was associated with age. Patients treated with HDF demonstrated seroprotection was sustained for longer compared to those treated by HD and greater lymphocyte proliferation to circulating influenza A strains. These encouraging results for HDF require confirmation in a larger dialysis population., Trial Registration: ClinicalTrial.gov, NCT04122222., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2020
- Full Text
- View/download PDF
30. Early transmission patterns of coronavirus disease 2019 (COVID-19) in travellers from Wuhan to Thailand, January 2020.
- Author
-
Okada P, Buathong R, Phuygun S, Thanadachakul T, Parnmen S, Wongboot W, Waicharoen S, Wacharapluesadee S, Uttayamakul S, Vachiraphan A, Chittaganpitch M, Mekha N, Janejai N, Iamsirithaworn S, Lee RT, and Maurer-Stroh S
- Subjects
- Aged, Betacoronavirus isolation & purification, COVID-19, China epidemiology, Chromosome Mapping, Disease Outbreaks, Female, Humans, Medical History Taking, Middle Aged, Phylogeny, Reverse Transcriptase Polymerase Chain Reaction, SARS-CoV-2, Thailand, Travel, Betacoronavirus genetics, Coronavirus Infections diagnosis, Coronavirus Infections epidemiology, Coronavirus Infections transmission, Genome, Viral, Pneumonia, Viral diagnosis, Pneumonia, Viral epidemiology, Pneumonia, Viral transmission
- Abstract
We report two cases of coronavirus disease 2019 (COVID-19) in travellers from Wuhan, China to Thailand. Both were independent introductions on separate flights, discovered with thermoscanners and confirmed with RT-PCR and genome sequencing. Both cases do not seem directly linked to the Huanan Seafood Market in Hubei but the viral genomes are identical to four other sequences from Wuhan, suggesting early spread within the city already in the first week of January.
- Published
- 2020
- Full Text
- View/download PDF
31. Enhanced surveillance for severe pneumonia, Thailand 2010-2015.
- Author
-
Bunthi C, Baggett HC, Gregory CJ, Thamthitiwat S, Yingyong T, Paveenkittiporn W, Kerdsin A, Chittaganpitch M, Ruangchira-Urai R, Akarasewi P, and Ungchusak K
- Subjects
- Adolescent, Adult, Child, Child, Preschool, Community-Acquired Infections microbiology, Female, Hospitalization, Hospitals statistics & numerical data, Humans, Infant, Male, Middle Aged, Middle East Respiratory Syndrome Coronavirus, Pneumonia microbiology, Respiratory Syncytial Virus, Human, Thailand epidemiology, Young Adult, Community-Acquired Infections epidemiology, Disease Outbreaks statistics & numerical data, Pneumonia epidemiology, Population Surveillance methods
- Abstract
Background: The etiology of severe pneumonia is frequently not identified by routine disease surveillance in Thailand. Since 2010, the Thailand Ministry of Public Health (MOPH) and US CDC have conducted surveillance to detect known and new etiologies of severe pneumonia., Methods: Surveillance for severe community-acquired pneumonia was initiated in December 2010 among 30 hospitals in 17 provinces covering all regions of Thailand. Interlinked clinical, laboratory, pathological and epidemiological components of the network were created with specialized guidelines for each to aid case investigation and notification. Severe pneumonia was defined as chest-radiograph confirmed pneumonia of unknown etiology in a patient hospitalized ≤48 h and requiring intubation with ventilator support or who died within 48 h after hospitalization; patients with underlying chronic pulmonary or neurological disease were excluded. Respiratory and pathological specimens were tested by reverse transcription polymerase chain reaction for nine viruses, including Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and 14 bacteria. Cases were reported via a secure web-based system., Results: Of specimens from 972 cases available for testing during December 2010 through December 2015, 589 (60.6%) had a potential etiology identified; 399 (67.8%) were from children aged < 5 years. At least one viral agent was detected in 394 (40.5%) cases, with the most common of single vial pathogen detected being respiratory syncytial virus (RSV) (110/589, 18.7%) especially in children under 5 years. Bacterial pathogens were detected in 341 cases of which 67 cases had apparent mixed infections. The system added MERS-CoV testing in September 2012 as part of Thailand's outbreak preparedness; no cases were identified from the 767 samples tested., Conclusions: Enhanced surveillance improved the understanding of the etiology of severe pneumonia cases and improved the MOPH's preparedness and response capacity for emerging respiratory pathogens in Thailand thereby enhanced global health security. Guidelines for investigation of severe pneumonia from this project were incorporated into surveillance and research activities within Thailand and shared for adaption by other countries.
- Published
- 2019
- Full Text
- View/download PDF
32. Viral etiologies of influenza-like illness and severe acute respiratory infections in Thailand.
- Author
-
Chittaganpitch M, Waicharoen S, Yingyong T, Praphasiri P, Sangkitporn S, Olsen SJ, and Lindblade KA
- Subjects
- Adolescent, Adult, Aged, Child, Child, Preschool, Female, Humans, Infant, Male, Middle Aged, Seasons, Thailand epidemiology, Young Adult, Respiratory Tract Infections epidemiology, Respiratory Tract Infections virology, Virus Diseases epidemiology, Virus Diseases virology
- Abstract
Background: Information on the burden, characteristics and seasonality of non-influenza respiratory viruses is limited in tropical countries., Objectives: Describe the epidemiology of selected non-influenza respiratory viruses in Thailand between June 2010 and May 2014 using a sentinel surveillance platform established for influenza., Methods: Patients with influenza-like illness (ILI; history of fever or documented temperature ≥38°C, cough, not requiring hospitalization) or severe acute respiratory infection (SARI; history of fever or documented temperature ≥38°C, cough, onset <10 days, requiring hospitalization) were enrolled from 10 sites. Throat swabs were tested for influenza viruses, respiratory syncytial virus (RSV), metapneumovirus (MPV), parainfluenza viruses (PIV) 1-3, and adenoviruses by polymerase chain reaction (PCR) or real-time reverse transcriptase-PCR., Results: We screened 15 369 persons with acute respiratory infections and enrolled 8106 cases of ILI (5069 cases <15 years old) and 1754 cases of SARI (1404 cases <15 years old). Among ILI cases <15 years old, influenza viruses (1173, 23%), RSV (447, 9%), and adenoviruses (430, 8%) were the most frequently identified respiratory viruses tested, while for SARI cases <15 years old, RSV (196, 14%) influenza (157, 11%) and adenoviruses (90, 6%) were the most common. The RSV season significantly overlapped the larger influenza season from July to November in Thailand., Conclusions: The global expansion of influenza sentinel surveillance provides an opportunity to gather information on the characteristics of cases positive for non-influenza respiratory viruses, particularly seasonality, although adjustments to case definitions may be required., (© 2018 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd.)
- Published
- 2018
- Full Text
- View/download PDF
33. The acceptability and validity of self-collected nasal swabs for detection of influenza virus infection among older adults in Thailand.
- Author
-
Goyal S, Prasert K, Praphasiri P, Chittaganpitch M, Waicharoen S, Ditsungnoen D, Jaichuang S, and Lindblade KA
- Subjects
- Aged, Aged, 80 and over, Female, Humans, Influenza, Human diagnosis, Influenza, Human epidemiology, Male, Nose virology, Respiratory Tract Infections diagnosis, Respiratory Tract Infections epidemiology, Respiratory Tract Infections virology, Sensitivity and Specificity, Thailand epidemiology, Influenza A virus isolation & purification, Influenza, Human virology, Nasopharynx virology, Specimen Handling methods
- Abstract
Background: Self-collection of nasal swabs could improve the timeliness of influenza virus detection in older adults., Objectives: Measure the acceptability, adequacy, timeliness, and validity of self-collected nasal swabs among adults >65 years in Thailand., Methods: Our evaluation consisted of two parts: a one-month study among randomly selected, community-dwelling older adults to simulate community-based surveillance for acute respiratory infections (ARI); and a clinic study of older adults with ARI to evaluate the sensitivity and specificity of self-collected nasal swabs for influenza virus infection compared with healthcare worker (HCW)-collected nasal and nasopharyngeal swabs., Results: In the community study, 24% of participants experienced an ARI during the observation period. All (100%) participants with an ARI self-collected nasal swabs within 72 hours of symptom onset of which 92% were considered adequate samples. In the clinic study, 45% of patients with ARI presented within 72 hours of symptom onset. The sensitivity of self-collected nasal swabs for detection of influenza virus infection was 78% (95% CI 40-97) compared to nasopharyngeal and 88% (95% CI 47-100) compared to nasal swabs collected by HCWs. Specificity was 100% (95% CI 97-100) compared to both methods. Self-collection of nasal swabs was found acceptable by 99% of participants in both studies., Conclusions: Self-collection of nasal swabs was acceptable to older adults in Thailand who were able to take adequate samples. Self-collection of nasal swabs may improve the timeliness of sample collection but lower sensitivity will need to be considered., (© 2017 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd.)
- Published
- 2017
- Full Text
- View/download PDF
34. The validity of clinical practice guidelines for empirical use of oseltamivir for influenza in Thai children.
- Author
-
Wongsawat J, Chittaganpitch M, Ampornareekul S, Srisophaa S, and Likanonsakul S
- Subjects
- Adolescent, Child, Child, Preschool, Female, Humans, Infant, Infant, Newborn, Male, Prospective Studies, Thailand, Antiviral Agents therapeutic use, Decision Support Techniques, Influenza, Human diagnosis, Influenza, Human drug therapy, Oseltamivir therapeutic use, Practice Guidelines as Topic
- Abstract
Background: Clinical practice guidelines for influenza have been implemented to maximise the appropriate use of empirical oseltamivir; however, good predictive values are required., Methods: Between October 2011 and September 2013, children aged < 15 years who presented at the Bamrasnaradura Infectious Diseases Institute with an influenza-like illness plus either (i) pneumonia or (ii) being in a higher risk group for influenza complications were prospectively enrolled. Respiratory specimens were taken for real-time polymerase chain reaction testing (RT-PCR). Clinical characteristics, laboratory data and oseltamivir therapy were recorded., Results: 85 cases were enrolled. Of these, the proportions of those with pneumonia, who were aged < 2 years and who had underlying diseases were 74.1%, 56.5% and 38.8%, respectively. RT-PCR detected respiratory syncytial virusamong (35.3%), influenza (22.3by%), adenovirus (14.1%), human metapneumovirus (5.9%), para-influenza (3.5%) and no viruses (25.9 %). Pneumonia (OR 0.16, 95% CI 0.05-0.50) and having two clinical criteria (OR 0.24, 95% CI 0.08-0.76) were significantly negative predictors of influenza. Having cluster transmissions (OR 5.18, 95% CI 1.38-19.37) and a monocyte proportion >7% (OR 3.58, 95% CI 1.15-11.17) were significantly positive predictors of influenza. The mean (SD) percentage of influenza-like illness during the study period was 7.04 (2.02)., Conclusions: Clinical criteria guidelines yielded a low predictive value (22.3%) for influenza in children. Seasonality, cluster transmission, white blood cell and differential counts may be helpful in diagnosing influenza. Nonetheless, empirical oseltamivir should not be delayed for those in need.
- Published
- 2016
- Full Text
- View/download PDF
35. Assessment of potential public health impact of a quadrivalent inactivated influenza vaccine in Thailand.
- Author
-
Kittikraisak W, Chittaganpitch M, Gregory CJ, Laosiritaworn Y, Thantithaveewat T, Dawood FS, and Lindblade KA
- Subjects
- Antibodies, Viral blood, Cost of Illness, Hospitalization, Humans, Influenza, Human epidemiology, Influenza, Human mortality, Models, Statistical, Seasons, Thailand epidemiology, Vaccines, Inactivated administration & dosage, Influenza B virus immunology, Influenza Vaccines administration & dosage, Influenza Vaccines economics, Influenza Vaccines immunology, Influenza, Human prevention & control, Influenza, Human virology, Public Health
- Abstract
Background: Each year, an influenza B strain representing only one influenza B lineage is included in the trivalent inactivated influenza vaccine (IIV3); a mismatch between the selected lineage and circulating viruses can result in suboptimal vaccine effectiveness. We modeled the added potential public health impact of a quadrivalent inactivated influenza vaccine (IIV4) that includes strains from both influenza B lineages compared to IIV3 on influenza-associated morbidity and mortality in Thailand., Methods: Using data on the incidence of influenza-associated hospitalizations and deaths, vaccine effectiveness, and vaccine coverage from the 2007-2012 influenza seasons in Thailand, we estimated rates of influenza-associated outcomes that might be averted using IIV4 instead of IIV3. We then applied these rates to national population estimates to calculate averted illnesses, hospitalizations, and deaths for each season. We assumed that the influenza B lineage included in IIV3 would provide a relative vaccine effectiveness of 75% against the other B lineage., Results: Compared to use of IIV3, use of IIV4 might have led to an additional reduction ranging from 0·4 to 14·3 influenza-associated illnesses per 100 000 population/year, <0·1 to 0·5 hospitalizations per 100 000/year, and <0·1 to 0·4 deaths per 1000/year. Based on extrapolation to national population estimates, replacement of IIV3 with IIV4 might have averted an additional 267-9784 influenza-associated illnesses, 9-320 hospitalizations, and 0-3 deaths., Conclusion: Compared to use of IIV3, IIV4 has the potential to further reduce the burden of influenza-associated morbidity and mortality in Thailand., (© 2015 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd.)
- Published
- 2016
- Full Text
- View/download PDF
36. Global Role and Burden of Influenza in Pediatric Respiratory Hospitalizations, 1982-2012: A Systematic Analysis.
- Author
-
Lafond KE, Nair H, Rasooly MH, Valente F, Booy R, Rahman M, Kitsutani P, Yu H, Guzman G, Coulibaly D, Armero J, Jima D, Howie SR, Ampofo W, Mena R, Chadha M, Sampurno OD, Emukule GO, Nurmatov Z, Corwin A, Heraud JM, Noyola DE, Cojocaru R, Nymadawa P, Barakat A, Adedeji A, von Horoch M, Olveda R, Nyatanyi T, Venter M, Mmbaga V, Chittaganpitch M, Nguyen TH, Theo A, Whaley M, Azziz-Baumgartner E, Bresee J, Campbell H, and Widdowson MA
- Subjects
- Adolescent, Child, Child, Preschool, Epidemiological Monitoring, Female, Global Health, Humans, Infant, Male, Respiratory Tract Diseases virology, Hospitalization statistics & numerical data, Influenza, Human epidemiology, Respiratory Tract Diseases epidemiology
- Abstract
Background: The global burden of pediatric severe respiratory illness is substantial, and influenza viruses contribute to this burden. Systematic surveillance and testing for influenza among hospitalized children has expanded globally over the past decade. However, only a fraction of the data has been used to estimate influenza burden. In this analysis, we use surveillance data to provide an estimate of influenza-associated hospitalizations among children worldwide., Methods and Findings: We aggregated data from a systematic review (n = 108) and surveillance platforms (n = 37) to calculate a pooled estimate of the proportion of samples collected from children hospitalized with respiratory illnesses and positive for influenza by age group (<6 mo, <1 y, <2 y, <5 y, 5-17 y, and <18 y). We applied this proportion to global estimates of acute lower respiratory infection hospitalizations among children aged <1 y and <5 y, to obtain the number and per capita rate of influenza-associated hospitalizations by geographic region and socio-economic status. Influenza was associated with 10% (95% CI 8%-11%) of respiratory hospitalizations in children <18 y worldwide, ranging from 5% (95% CI 3%-7%) among children <6 mo to 16% (95% CI 14%-20%) among children 5-17 y. On average, we estimated that influenza results in approximately 374,000 (95% CI 264,000 to 539,000) hospitalizations in children <1 y-of which 228,000 (95% CI 150,000 to 344,000) occur in children <6 mo-and 870,000 (95% CI 610,000 to 1,237,000) hospitalizations in children <5 y annually. Influenza-associated hospitalization rates were more than three times higher in developing countries than in industrialized countries (150/100,000 children/year versus 48/100,000). However, differences in hospitalization practices between settings are an important limitation in interpreting these findings., Conclusions: Influenza is an important contributor to respiratory hospitalizations among young children worldwide. Increasing influenza vaccination coverage among young children and pregnant women could reduce this burden and protect infants <6 mo., Competing Interests: We have read the journal's policy and have the following competing interests: DEN has participated on an influenza advisory board for Novartis. RB works with all major manufacturers of influenza vaccines in an advisory capacity, as a researcher on vaccines and as presenter of academic info at conferences, receiving support to travel and attend such conferences. The authors have declared that no other competing interests exist.
- Published
- 2016
- Full Text
- View/download PDF
37. Influenza-associated mortality in Thailand, 2006-2011.
- Author
-
Aungkulanon S, Cheng PY, Kusreesakul K, Bundhamcharoen K, Chittaganpitch M, Margaret M, and Olsen S
- Abstract
Background: Influenza-associated mortality in subtropical or tropical regions, particularly in developing countries, remains poorly quantified and often underestimated. We analyzed data in Thailand, a middle-income tropical country with good vital statistics and influenza surveillance data., Methods: We obtained weekly mortality data for all-cause and three underlying causes of death (circulatory and respiratory diseases, and pneumonia and influenza), and weekly influenza virus data, from 2006 to 2011. A negative binomial regression model was used to estimate deaths attributable to influenza in two age groups (<65 and ≥65 years) by incorporating influenza viral data as covariates in the model., Results: From 2006 to 2011, the average annual influenza-associated mortality per 100 000 persons was 4·0 (95% CI: -18 to 26). Eighty-three percent of influenza-associated deaths occurred among persons aged > 65 years. The average annual rate of influenza-associated deaths was 0·7 (95% CI: -8·2 to 10) per 100 000 population for person aged <65 years and 42 (95% CI: -137 to 216) for person aged ≥ 65 years., Discussion: In Thailand, estimated excess mortality associated with influenza was considerable even during non-pandemic years. These data provide support for Thailand's seasonal influenza vaccination campaign. Continued monitoring of mortality data is important to assess impact., (© 2015 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd.)
- Published
- 2015
- Full Text
- View/download PDF
38. Mortality attributable to seasonal influenza A and B infections in Thailand, 2005-2009: a longitudinal study.
- Author
-
Cooper BS, Kotirum S, Kulpeng W, Praditsitthikorn N, Chittaganpitch M, Limmathurotsakul D, Day NP, Coker R, Teerawattananon Y, and Meeyai A
- Subjects
- Adolescent, Adult, Age Distribution, Bayes Theorem, Cause of Death, Female, Humans, Influenza A Virus, H1N1 Subtype, Influenza A Virus, H3N2 Subtype, Influenza, Human epidemiology, Longitudinal Studies, Male, Middle Aged, Sentinel Surveillance, Thailand, Young Adult, Influenza A virus, Influenza B virus, Influenza, Human mortality, Seasons
- Abstract
Influenza epidemiology differs substantially in tropical and temperate zones, but estimates of seasonal influenza mortality in developing countries in the tropics are lacking. We aimed to quantify mortality due to seasonal influenza in Thailand, a tropical middle-income country. Time series of polymerase chain reaction-confirmed influenza infections between 2005 and 2009 were constructed from a sentinel surveillance network. These were combined with influenza-like illness data to derive measures of influenza activity and relationships to mortality by using a Bayesian regression framework. We estimated 6.1 (95% credible interval: 0.5, 12.4) annual deaths per 100,000 population attributable to influenza A and B, predominantly in those aged ≥60 years, with the largest contribution from influenza A(H1N1) in 3 out of 4 years. For A(H3N2), the relationship between influenza activity and mortality varied over time. Influenza was associated with increases in deaths classified as resulting from respiratory disease (posterior probability of positive association, 99.8%), cancer (98.6%), renal disease (98.0%), and liver disease (99.2%). No association with circulatory disease mortality was found. Seasonal influenza infections are associated with substantial mortality in Thailand, but evidence for the strong relationship between influenza activity and circulatory disease mortality reported in temperate countries is lacking., (© The Author 2015. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health.)
- Published
- 2015
- Full Text
- View/download PDF
39. Detecting Spread of Avian Influenza A(H7N9) Virus Beyond China.
- Author
-
Millman AJ, Havers F, Iuliano AD, Davis CT, Sar B, Sovann L, Chin S, Corwin AL, Vongphrachanh P, Douangngeun B, Lindblade KA, Chittaganpitch M, Kaewthong V, Kile JC, Nguyen HT, Pham DV, Donis RO, and Widdowson MA
- Subjects
- Animals, Asia, Southeastern epidemiology, China epidemiology, Disease Outbreaks, Geography, Humans, Influenza A Virus, H5N1 Subtype, Influenza in Birds virology, Influenza, Human virology, Population Surveillance, Poultry, Influenza A Virus, H7N9 Subtype, Influenza in Birds epidemiology, Influenza in Birds transmission, Influenza, Human epidemiology, Influenza, Human transmission
- Abstract
During February 2013-March 2015, a total of 602 human cases of low pathogenic avian influenza A(H7N9) were reported; no autochthonous cases were reported outside mainland China. In contrast, since highly pathogenic avian influenza A(H5N1) reemerged during 2003 in China, 784 human cases in 16 countries and poultry outbreaks in 53 countries have been reported. Whether the absence of reported A(H7N9) outside mainland China represents lack of spread or lack of detection remains unclear. We compared epidemiologic and virologic features of A(H5N1) and A(H7N9) and used human and animal influenza surveillance data collected during April 2013-May 2014 from 4 Southeast Asia countries to assess the likelihood that A(H7N9) would have gone undetected during 2014. Surveillance in Vietnam and Cambodia detected human A(H5N1) cases; no A(H7N9) cases were detected in humans or poultry in Southeast Asia. Although we cannot rule out the possible spread of A(H7N9), substantial spread causing severe disease in humans is unlikely.
- Published
- 2015
- Full Text
- View/download PDF
40. A human monoclonal antibody derived from a vaccinated volunteer recognizes heterosubtypically a novel epitope on the hemagglutinin globular head of H1 and H9 influenza A viruses.
- Author
-
Boonsathorn N, Panthong S, Koksunan S, Chittaganpitch M, Phuygun S, Waicharoen S, Prachasupap A, Sasaki T, Kubota-Koketsu R, Yasugi M, Ono K, Arai Y, Kurosu T, Sawanpanyalert P, Ikuta K, and Watanabe Y
- Subjects
- Amino Acid Sequence, Animals, Antigens, Viral chemistry, Antigens, Viral immunology, Epitope Mapping, Epitopes chemistry, Epitopes immunology, Hemagglutination Inhibition Tests, Hemagglutinin Glycoproteins, Influenza Virus chemistry, Hemagglutinin Glycoproteins, Influenza Virus immunology, Humans, Hybridomas immunology, Influenza Vaccines administration & dosage, Influenza, Human immunology, Influenza, Human virology, Male, Mice, Models, Molecular, Molecular Sequence Data, Protein Conformation, Vaccination, Young Adult, Antibodies, Monoclonal biosynthesis, Antibodies, Neutralizing biosynthesis, Antibodies, Viral biosynthesis, Cross Protection, Influenza A Virus, H1N1 Subtype immunology, Influenza A Virus, H9N2 Subtype immunology, Influenza, Human prevention & control
- Abstract
Most neutralizing antibodies elicited during influenza virus infection or by vaccination have a narrow spectrum because they usually target variable epitopes in the globular head region of hemagglutinin (HA). In this study, we describe a human monoclonal antibody (HuMAb), 5D7, that was prepared from the peripheral blood lymphocytes of a vaccinated volunteer using the fusion method. The HuMAb heterosubtypically neutralizes group 1 influenza A viruses, including seasonal H1N1, 2009 pandemic H1N1 (H1N1pdm) and avian H9N2, with a strong hemagglutinin inhibition activity. Selection of an escape mutant showed that the HuMAb targets a novel conformational epitope that is located in the HA head region but is distinct from the receptor binding site. Furthermore, Phe114Ile substitution in the epitope made the HA unrecognizable by the HuMAb. Amino acid residues in the predicted epitope region are also highly conserved in the HAs of H1N1 and H9N2. The HuMAb reported here may be a potential candidate for the development of therapeutic/prophylactic antibodies against H1 and H9 influenza viruses., (Copyright © 2014 Elsevier Inc. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
41. High rate of A(H1N1)pdm09 infections among rural Thai villagers, 2009-2010.
- Author
-
Khuntirat B, Yoon IK, Chittaganpitch M, Krueger WS, Supawat K, Blair PJ, Putnam SD, Gibbons RV, Buddhari D, Sawanpanyalert P, Heil GL, Friary JA, and Gray GC
- Subjects
- Adolescent, Adult, Aged, Asymptomatic Infections, Child, Child, Preschool, Family Characteristics, Female, Hemagglutination Inhibition Tests, Humans, Incidence, Infant, Influenza A Virus, H1N1 Subtype physiology, Influenza, Human physiopathology, Influenza, Human transmission, Male, Middle Aged, Prospective Studies, Rural Population, Thailand epidemiology, Influenza A Virus, H1N1 Subtype pathogenicity, Influenza, Human epidemiology, Pandemics
- Abstract
Background: Pandemic influenza A(H1N1)pdm09 emerged in Thailand in 2009. A prospective longitudinal adult cohort and household transmission study of influenza-like illness (ILI) was ongoing in rural Thailand at the time of emergence. Symptomatic and subclinical A(H1N1)pdm09 infection rates in the cohort and among household members were evaluated., Methods: A cohort of 800 Thai adults underwent active community-based surveillance for ILI from 2008-2010. Acute respiratory samples from ILI episodes were tested for A(H1N1)pdm09 by qRT-PCR; acute and 60-day convalescent blood samples were tested by A(H1N1)pdm09 hemagglutination inhibition assay (HI). Enrollment, 12-month and 24-month follow-up blood samples were tested for A(H1N1)pdm09 seroconversion by HI. Household members of influenza A-infected cohort subjects with ILI were enrolled in household transmission investigations in which day 0 and 60 blood samples and acute respiratory samples were tested by either qRT-PCR or HI for A(H1N1)pdm09. Seroconversion between annual blood samples without A(H1N1)pdm09-positive ILI was considered as subclinical infection., Results: The 2-yr cumulative incidence of A(H1N1)pdm09 infection in the cohort in 2009/2010 was 10.8% (84/781) with an annual incidence of 1.2% in 2009 and 9.7% in 2010; 83.3% of infections were subclinical (50% in 2009 and 85.9% in 2010). The 2-yr cumulative incidence was lowest (5%) in adults born ≤ 1957. The A(H1N1)pdm09 secondary attack rate among household contacts was 47.2% (17/36); 47.1% of these infections were subclinical. The highest A(H1N1)pdm09 secondary attack rate among household contacts (70.6%, 12/17) occurred among children born between 1990 and 2003., Conclusion: Subclinical A(H1N1)pdm09 infections in Thai adults occurred frequently and accounted for a greater proportion of all A(H1N1)pdm09 infections than previously estimated. The role of subclinical infections in A(H1N1)pdm09 transmission has important implications in formulating strategies to predict and prevent the spread of A(H1N1)pdm09 and other influenza virus strains.
- Published
- 2014
- Full Text
- View/download PDF
42. Effectiveness of the 2010 and 2011 Southern Hemisphere trivalent inactivated influenza vaccines against hospitalization with influenza-associated acute respiratory infection among Thai adults aged ≥ 50 years.
- Author
-
Dawood FS, Prapasiri P, Areerat P, Ruayajin A, Chittaganpitch M, Muangchana C, Baggett HC, and Olsen SJ
- Subjects
- Aged, Aged, 80 and over, Animals, Case-Control Studies, Female, Humans, Influenza Vaccines administration & dosage, Male, Middle Aged, Orthomyxoviridae genetics, Orthomyxoviridae isolation & purification, Real-Time Polymerase Chain Reaction, Reverse Transcriptase Polymerase Chain Reaction, Rural Population, Thailand, Treatment Outcome, Hospitalization statistics & numerical data, Influenza Vaccines immunology, Influenza, Human prevention & control
- Abstract
Background: Inactivated influenza vaccine (IIV) effectiveness has been evaluated among older adults in high-income countries, but data on IIV effectiveness in low- and middle-income countries remain sparse. We conducted a test-negative case-control analysis to estimate 2010 and 2011 trivalent IIV effectiveness against hospitalization with influenza-associated acute respiratory infection (ARI) among persons aged ≥ 50 years in rural Thailand., Methods: During 2010-2011, active surveillance for ARI hospitalization was conducted in two provinces; patients were tested for influenza viruses by real-time RT-PCR. Vaccination status was obtained from vaccine registries. Case and control patients were patients with nasopharyngeal swabs positive and negative for influenza viruses, respectively. Vaccine effectiveness (VE) was estimated for the 6 months after vaccination began. Logistic regression was used to evaluate the association between case status and vaccination while adjusting for age, province, medical conditions, and time., Results: During 2010-2011, there were 1545 patients with ARI, of whom 279 (18%) were influenza-positive case patients and 1266 (82%) were influenza-negative control patients. Of the 279 case patients, 247 (89%) had influenza A and 32 (11%) had influenza B. Fourteen of 279 (5%) case patients and 108 of 1266 (9%) control patients were vaccinated against influenza. The unadjusted IIV effectiveness against hospitalization with influenza-associated ARI was 43% (95% CI: 0-68%); adjusted VE was 47% (95% CI: 5-71%)., Conclusion: The 2010 and 2011 IIVs were moderately effective against hospitalization with influenza-associated ARI among Thais aged ≥ 50 years, but IIV coverage was low. Additional efforts are warranted in Thailand to improve IIV uptake in this target group., (© 2014 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd.)
- Published
- 2014
- Full Text
- View/download PDF
43. Risk factors and outcomes of influenza infection among children presenting with influenza-like illness.
- Author
-
Vandepitte WP, Netsawang S, Suntarattiwong P, Srisarang S, Chittaganpitch M, and Chotpitayasunondh T
- Subjects
- Child, Child, Preschool, DNA, Viral analysis, Female, Humans, Infant, Infant, Newborn, Infant, Premature, Male, Multivariate Analysis, Odds Ratio, Orthomyxoviridae, Polymerase Chain Reaction, Pregnancy, Regression Analysis, Risk Factors, Thailand, Treatment Outcome, Influenza, Human epidemiology, Influenza, Human therapy
- Abstract
Objective: Limited data were available to guide management, counseling, and/or diagnostic investigation among children presenting with influenza-like illness (ILI). During a recent period of high influenza activity, we wished to determine the frequency, outcomes, and factors associated with influenza infection among children presenting with ILI., Material and Method: During September and October 2010, children presenting with ILI were enrolled. Nasal swabs were sent for polymerase chain reaction (PCR) to determine the frequency and types of influenza. Information of demographic characteristics, potential risk factors, and short-term outcomes of study participants were collected., Results: Among 300 enrolled subjects, influenza infections were identified in 170 (56.7%) cases; 45.7% (n = 137) were influenza A and 11% (n = 33) were influenza B. Most cases recovered uneventfully with a 3.7% (n = 11) hospitalization rate. Risks for hospitalization did not differ by infection status (2.4% vs. 5.4% between those with and without influenza infection, respectively) or types of influenza infection. Logistic regression analysis indicated that older age, having a household member with acute respiratory illness (ARI) during the previous 7 days, having an underlying co-morbidity, and a history of premature birth were associated with influenza, with adjusted odds ratios and 95% confidence intervals of 1.19 (1.087, 1.30), 3.21 (1.096, 9.424), 2.15 (1.244, 3.728), and 0.08 (0.007, 0.876), respectively., Conclusion: The outcomes of influenza-associated ILI were generally favourable, with no fatalities and 2.4% risk for hospitalization. Among children presenting with ILI, age, household contact with ARI, and co morbidities increased the likelihood of influenza, whereas history of premature birth was negatively associated with influenza.
- Published
- 2014
44. Influenza seasonality and vaccination timing in tropical and subtropical areas of southern and south-eastern Asia.
- Author
-
Saha S, Chadha M, Al Mamun A, Rahman M, Sturm-Ramirez K, Chittaganpitch M, Pattamadilok S, Olsen SJ, Sampurno OD, Setiawaty V, Pangesti KN, Samaan G, Archkhawongs S, Vongphrachanh P, Phonekeo D, Corwin A, Touch S, Buchy P, Chea N, Kitsutani P, Mai le Q, Thiem VD, Lin R, Low C, Kheong CC, Ismail N, Yusof MA, Tandoc A 3rd, Roque V Jr, Mishra A, Moen AC, Widdowson MA, Partridge J, and Lal RB
- Subjects
- Asia, Southeastern epidemiology, Humans, Influenza Vaccines, Influenza, Human prevention & control, Nasal Mucosa virology, Orthomyxoviridae immunology, Seasons, Tropical Climate, Influenza, Human epidemiology, Influenza, Human virology, Orthomyxoviridae isolation & purification
- Abstract
Objective: To characterize influenza seasonality and identify the best time of the year for vaccination against influenza in tropical and subtropical countries of southern and south-eastern Asia that lie north of the equator., Methods: Weekly influenza surveillance data for 2006 to 2011 were obtained from Bangladesh, Cambodia, India, Indonesia, the Lao People's Democratic Republic, Malaysia, the Philippines, Singapore, Thailand and Viet Nam. Weekly rates of influenza activity were based on the percentage of all nasopharyngeal samples collected during the year that tested positive for influenza virus or viral nucleic acid on any given week. Monthly positivity rates were then calculated to define annual peaks of influenza activity in each country and across countries., Findings: Influenza activity peaked between June/July and October in seven countries, three of which showed a second peak in December to February. Countries closer to the equator had year-round circulation without discrete peaks. Viral types and subtypes varied from year to year but not across countries in a given year. The cumulative proportion of specimens that tested positive from June to November was > 60% in Bangladesh, Cambodia, India, the Lao People's Democratic Republic, the Philippines, Thailand and Viet Nam. Thus, these tropical and subtropical countries exhibited earlier influenza activity peaks than temperate climate countries north of the equator., Conclusion: Most southern and south-eastern Asian countries lying north of the equator should consider vaccinating against influenza from April to June; countries near the equator without a distinct peak in influenza activity can base vaccination timing on local factors.
- Published
- 2014
- Full Text
- View/download PDF
45. Incidence and etiology of acute lower respiratory tract infections in hospitalized children younger than 5 years in rural Thailand.
- Author
-
Hasan R, Rhodes J, Thamthitiwat S, Olsen SJ, Prapasiri P, Naorat S, Chittaganpitch M, Henchaichon S, Dejsirilert S, Srisaengchai P, Sawatwong P, Jorakate P, Kaewpwan A, Fry AM, Erdman D, Chuananon S, Amornintapichet T, Maloney SA, and Baggett HC
- Subjects
- Bacteremia epidemiology, Bacteremia microbiology, Bacteremia virology, Child, Preschool, Female, Hospitalization, Humans, Incidence, Infant, Infant, Newborn, Male, Pneumonia epidemiology, Pneumonia microbiology, Pneumonia virology, Respiratory Tract Infections microbiology, Respiratory Tract Infections virology, Rural Population, Thailand epidemiology, Respiratory Tract Infections epidemiology
- Abstract
Background: Pneumonia remains a leading cause of under-five morbidity and mortality globally. Comprehensive incidence, epidemiologic and etiologic data are needed to update prevention and control strategies., Methods: We conducted active, population-based surveillance for hospitalized cases of acute lower respiratory tract infections (ALRI) among children <5 years of age in rural Thailand. ALRI cases were systematically sampled for an etiology study that tested nasopharyngeal specimens by polymerase chain reaction; children without ALRI were enrolled as controls from outpatient clinics., Results: We identified 28,543 hospitalized ALRI cases from 2005 to 2010. Among the 49% with chest radiographs, 76% had findings consistent with pneumonia as identified by 2 study radiologists. The hospitalized ALRI incidence rate was 5772 per 100,000 child-years (95% confidence interval: 5707, 5837) and was higher in boys versus girls (incidence rate ratio 1.38, 95% confidence interval: 1.35-1.41) and in children 6-23 months of age versus other age groups (incidence rate ratio 1.76, 95% confidence interval: 1.69-1.84). Viruses most commonly detected in ALRI cases were respiratory syncytial virus (19.5%), rhinoviruses (18.7%), bocavirus (12.8%) and influenza viruses (8%). Compared with controls, ALRI cases were more likely to test positive for respiratory syncytial virus, influenza, adenovirus, human metapneumovirus and parainfluenza viruses 1 and 3 (P ≤ 0.01 for all). Bloodstream infections, most commonly Streptococcus pneumoniae and nontyphoidal Salmonella, accounted for 1.8% of cases., Conclusions: Our findings underscore the high burden of hospitalization for ALRI and the importance of viral pathogens among children in Thailand. Interventions targeting viral pathogens coupled with improved diagnostic approaches, especially for bacteria, are critical for better understanding of ALRI etiology, prevention and control.
- Published
- 2014
- Full Text
- View/download PDF
46. Hospitalization due to human parainfluenza virus-associated lower respiratory tract illness in rural Thailand.
- Author
-
Morgan OW, Chittaganpitch M, Clague B, Chantra S, Sanasuttipun W, Prapasiri P, Naorat S, Laosirithavorn Y, Peret TC, Erdman DD, Baggett HC, Olsen SJ, and Fry AM
- Subjects
- Adolescent, Adult, Aged, Child, Child, Preschool, Female, Hospitalization, Humans, Infant, Male, Middle Aged, Molecular Sequence Data, Paramyxoviridae Infections therapy, Paramyxovirinae classification, Paramyxovirinae genetics, Respiratory Tract Infections therapy, Rural Health, Thailand epidemiology, Young Adult, Paramyxoviridae Infections epidemiology, Paramyxoviridae Infections virology, Paramyxovirinae isolation & purification, Respiratory Tract Infections epidemiology, Respiratory Tract Infections virology
- Abstract
Background: Human parainfluenza viruses (HPIVs) are an important cause of acute respiratory illness in young children but little is known about their epidemiology in the tropics., Methods: From 2003-2007, we conducted surveillance for hospitalized respiratory illness in rural Thailand. We performed reverse-transcriptase polymerase chain reaction on nasopharyngeal specimens and enzyme immunoassay on paired sera., Results: Of 10,097 patients enrolled, 573 (5%) of all ages and 370 (9%) of children <5 years of age had evidence of HPIV infection (HPIV1=189, HPIV2=54, HPIV3=305, untyped=27). Average adjusted annual incidence of HPIV-associated hospitalized respiratory illness was greatest in children aged <1 year (485 per 100,000 person years)., Conclusions: In Thailand, HPIV caused substantial illnesses requiring hospitalization in young children., (Published 2012. This article is a US Government work and is in the public domain in the USA.)
- Published
- 2013
- Full Text
- View/download PDF
47. Concurrent influenza virus infection and tuberculosis in patients hospitalized with respiratory illness in Thailand.
- Author
-
Roth S, Whitehead S, Thamthitiwat S, Chittaganpitch M, Maloney SA, Baggett HC, and Olsen SJ
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Child, Coinfection microbiology, Coinfection virology, Hospitalization, Humans, Influenza, Human complications, Influenza, Human virology, Male, Middle Aged, Orthomyxoviridae genetics, Orthomyxoviridae isolation & purification, Respiratory Tract Infections epidemiology, Retrospective Studies, Thailand epidemiology, Tuberculosis complications, Tuberculosis microbiology, Young Adult, Coinfection epidemiology, Influenza, Human epidemiology, Orthomyxoviridae physiology, Respiratory Tract Infections virology, Tuberculosis epidemiology
- Abstract
Thailand, where influenza viruses circulate year-round, is one of 22 WHO-designated high-burden countries for tuberculosis (TB). Surveillance for hospitalized respiratory illness between 2003 and 2011 revealed 23 (<1% of 7180 tested) with concurrent influenza and TB. Only two persons were previously known to have TB suggesting that acute respiratory illness may bring patients to medical attention and lead to TB diagnosis. Influenza/TB was not associated with higher disease severity or mortality., (© 2012 Blackwell Publishing Ltd.)
- Published
- 2013
- Full Text
- View/download PDF
48. Efficacy of the trivalent influenza vaccination in Thai patients with hemodialysis or kidney transplant compared with healthy volunteers.
- Author
-
Krairittichai U and Chittaganpitch M
- Subjects
- Adult, Chi-Square Distribution, Cross-Sectional Studies, Female, Humans, Immunocompromised Host, Influenza A Virus, H1N1 Subtype immunology, Influenza A Virus, H3N2 Subtype immunology, Influenza B virus immunology, Male, Thailand, Influenza Vaccines immunology, Influenza, Human immunology, Influenza, Human prevention & control, Kidney Transplantation immunology, Renal Dialysis
- Abstract
Objective: To evaluate the immune response to trivalent influenza vaccination in Thai patients with hemodialysis (HD) or kidney transplant (KT) compared with healthy volunteers., Material and Method: This was a cross-sectional study in Thai healthy volunteers and patients with HD and KT who received the trivalent influenza vaccine provided by the Ministry of Public Health of Thailand from 1 November 2011 to 31 December 2011. Each subject was injected intramuscularly with one dose (0.5 milliliter) of trivalent influenza vaccine containing viral strains recommended by the WHO for the 2011 influenza season (southern hemisphere). Blood samples before and 6 weeks after the vaccination were measured for immune response using a hemagglutination-inhibition antibody assay., Results: Subjects consisted of 30 healthy volunteers, 30 patients with HD and 30 patients with KT Prevalence of pre-vaccination seroprotective (SP) immunity in each group (healthy volunteers, HD, KT) was as follows: against H1N1 (33.3%: 23.3%: 10.0%), H3N2 (80.0%: 26.7%: 23.3%) and B (60.0%: 20.0%: 3.30%) viral strains, respectively. Those who were seronegative (SN) before testing positive after one dose of this vaccine were as follows: H1N1 (100.0%: 73.9%: 74.1%), H3N2 (66.7%: 86.4%: 34.8%) or B (58.3%: 66. 7%: 48.3%) viral strains, respectively. The healthy group showed significantly higher SP immune response for H1N1 than the HD and KT groups (p = 0.023). The HD group had significantly higher SP immune response for H3N2 than the KT groups (p = 0.001). Immune responses for the B vaccine in all groups were not different. No major adverse event was found in any group., Conclusion: Immune response for H1N1 vaccine in the HD and KT groups was slightly less than that of the healthy group. Immune response for H3N2 vaccine in the KT groups was less than in the healthy and HD groups. Immune responses for B vaccine in all groups were not different.
- Published
- 2013
49. Influenza antiviral resistance in the Asia-Pacific region during 2011.
- Author
-
Leang SK, Deng YM, Shaw R, Caldwell N, Iannello P, Komadina N, Buchy P, Chittaganpitch M, Dwyer DE, Fagan P, Gourinat AC, Hammill F, Horwood PF, Huang QS, Ip PK, Jennings L, Kesson A, Kok T, Kool JL, Levy A, Lin C, Lindsay K, Osman O, Papadakis G, Rahnamal F, Rawlinson W, Redden C, Ridgway J, Sam IC, Svobodova S, Tandoc A, Wickramasinghe G, Williamson J, Wilson N, Yusof MA, Kelso A, Barr IG, and Hurt AC
- Subjects
- Asia, Humans, Influenza A virus isolation & purification, Influenza B virus isolation & purification, Inhibitory Concentration 50, Microbial Sensitivity Tests, Pacific Islands, Antiviral Agents pharmacology, Influenza A virus drug effects, Influenza B virus drug effects, Influenza, Human virology
- Abstract
Despite greater than 99% of influenza A viruses circulating in the Asia-Pacific region being resistant to the adamantane antiviral drugs in 2011, the large majority of influenza A (>97%) and B strains (∼99%) remained susceptible to the neuraminidase inhibitors oseltamivir and zanamivir. However, compared to the first year of the 2009 pandemic, cases of oseltamivir-resistant A(H1N1)pdm09 viruses with the H275Y neuraminidase mutation increased in 2011, primarily due to an outbreak of oseltamivir-resistant viruses that occurred in Newcastle, as reported in Hurt et al. (2011c, 2012a), where the majority of the resistant viruses were from community patients not being treated with oseltamivir. A small number of influenza B viruses with reduced oseltamivir or zanamivir susceptibility were also detected. The increased detection of neuraminidase inhibitor resistant strains circulating in the community and the detection of novel variants with reduced susceptibility are reminders that monitoring of influenza viruses is important to ensure that antiviral treatment guidelines remain appropriate., (Copyright © 2012. Published by Elsevier B.V.)
- Published
- 2013
- Full Text
- View/download PDF
50. Influenza viruses in Thailand: 7 years of sentinel surveillance data, 2004-2010.
- Author
-
Chittaganpitch M, Supawat K, Olsen SJ, Waicharoen S, Patthamadilok S, Yingyong T, Brammer L, Epperson SP, Akrasewi P, and Sawanpanyalert P
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Child, Child, Preschool, Hemagglutination Inhibition Tests, Humans, Infant, Infant, Newborn, Male, Middle Aged, Pharynx virology, Polymerase Chain Reaction, Seasons, Sentinel Surveillance, Thailand epidemiology, Virus Cultivation, Young Adult, Influenza, Human epidemiology, Influenza, Human virology, Orthomyxoviridae classification, Orthomyxoviridae isolation & purification
- Abstract
Background: The re-emergence of avian influenza A (H5N1) in 2004 and the pandemic of influenza A (H1N1) in 2009 highlight the need for routine surveillance systems to monitor influenza viruses, particularly in Southeast Asia where H5N1 is endemic in poultry. In 2004, the Thai National Institute of Health, in collaboration with the U.S. Centers for Disease Control and Prevention, established influenza sentinel surveillance throughout Thailand., Objectives: To review routine epidemiologic and virologic surveillance for influenza viruses for public health action., Methods: Throat swabs from persons with influenza-like illness and severe acute respiratory illness were collected at 11 sentinel sites during 2004-2010. Influenza viruses were identified using the standard protocol for polymerase chain reaction. Viruses were cultured and identified by immunofluorescence assay; strains were identified by hemagglutination inhibition assay. Data were analyzed to describe frequency, seasonality, and distribution of circulating strains., Results: Of the 19,457 throat swabs, 3967 (20%) were positive for influenza viruses: 2663 (67%) were influenza A and able to be subtyped [21% H1N1, 25% H3N2, 21% pandemic (pdm) H1N1] and 1304 (33%) were influenza B. During 2009-2010, the surveillance system detected three waves of pdm H1N1. Influenza annually presents two peaks, a major peak during the rainy season (June-August) and a minor peak in winter (October-February)., Conclusions: These data suggest that March-April may be the most appropriate months for seasonal influenza vaccination in Thailand. This system provides a robust profile of the epidemiology of influenza viruses in Thailand and has proven useful for public health planning., (© 2011 Blackwell Publishing Ltd.)
- Published
- 2012
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.